• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
  • AUXILIARY MENU
Menu
GOVPH
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

DOST - Health Technology Assessment Official Logo
Republic of the Philippines
DOST - Health Technology Assessment

Philippine Standard Time:

Evidence brief for 09 October to 15 October 2021

Posted on October 19, 2021

For the period of 09 October to 15 October 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 09 October to 15 October 2021

Evidence brief for 02 October to 08 October 2021

Posted on October 19, 2021

For the period of  02 October to 08 October 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 02 October to 08 October 2021

Evidence brief for 25 September to 01 October 2021

Posted on October 4, 2021

For the period of  25 September to 01 October 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 25 September to 01 October 2021

Evidence brief for 18 September to 24 September 2021

Posted on September 27, 2021

For the period of  18 September to 24 September 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 18 September to 24 September

[Department Circular No. 2021- 0410] Inclusion of Two-Dose Inactivated Polio Vaccine (IPV) in the Philippine National Formulary (PNF)

Posted on September 20, 2021

Post navigation

← Older posts
Newer posts →